Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects

NCT00413608 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Clopidogrel

Sponsor

Assistance Publique - Hôpitaux de Paris